Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

GSK3β, CREB, and BDNF in peripheral blood of patients with Alzheimer's disease and depression
Jan Plátenı́k, Zdeněk Fišar, Richard Buchal, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2013) Vol. 50, pp. 83-93
Closed Access | Times Cited: 150

Showing 1-25 of 150 citing articles:

The involvement of BDNF, NGF and GDNF in aging and Alzheimer's disease
Josiane, Tatiani, Francielle, et al.
Aging and Disease (2015) Vol. 6, Iss. 5, pp. 331-331
Open Access | Times Cited: 362
Decreased Serum Brain-Derived Neurotrophic Factor (BDNF) Levels in Patients with Alzheimer’s Disease (AD): A Systematic Review and Meta-Analysis
Ted Kheng Siang Ng, Cyrus S. H. Ho, Wilson Tam, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 2, pp. 257-257
Open Access | Times Cited: 335
Brain-derived neurotrophic factor in Alzheimer’s disease and its pharmaceutical potential
Li-Na Gao, Yun Zhang, Keenan Sterling, et al.
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 327
The role of CREB and BDNF in neurobiology and treatment of Alzheimer's disease
Meysam Amidfar, Jade de Oliveira, Ewa Kucharska, et al.
Life Sciences (2020) Vol. 257, pp. 118020-118020
Closed Access | Times Cited: 302
Biological hypotheses and biomarkers of bipolar disorder
Ekaterina Sigitova, Zdeněk Fišar, Jana Hroudová, et al.
Psychiatry and Clinical Neurosciences (2016) Vol. 71, Iss. 2, pp. 77-103
Open Access | Times Cited: 212
Brain-Derived Neurotrophic Factor in Alzheimer’s Disease: Risk, Mechanisms, and Therapy
Jinghui Song, Jin‐Tai Yu, Lan Tan
Molecular Neurobiology (2014) Vol. 52, Iss. 3, pp. 1477-1493
Closed Access | Times Cited: 210
Butyrate enhances mitochondrial function during oxidative stress in cell lines from boys with autism
Shannon Rose, Sirish C. Bennuri, Jakeira E. Davis, et al.
Translational Psychiatry (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 180
Recent Advances on the Role of Brain-Derived Neurotrophic Factor (BDNF) in Neurodegenerative Diseases
Khairunnuur Fairuz Azman, Rahimah Zakaria
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6827-6827
Open Access | Times Cited: 125
The Role of BDNF as a Biomarker in Cognitive and Sensory Neurodegeneration
Anna Pisani, Fabiola Paciello, V. Del Vecchio, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 4, pp. 652-652
Open Access | Times Cited: 44
Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review
Biswanath Dinda, Manikarna Dinda, Goutam Kulsi, et al.
European Journal of Medicinal Chemistry (2019) Vol. 169, pp. 185-199
Closed Access | Times Cited: 144
Determinants of behavioral and psychological symptoms of dementia: A scoping review of the evidence
Ann Kolanowski, Marie Boltz, Elizabeth Galik, et al.
Nursing Outlook (2017) Vol. 65, Iss. 5, pp. 515-529
Open Access | Times Cited: 139
Antidepressant Flavonoids and Their Relationship with Oxidative Stress
Lucian Hrițcu, Radu Ioniță, Paula Alexandra Postu, et al.
Oxidative Medicine and Cellular Longevity (2017) Vol. 2017, Iss. 1
Open Access | Times Cited: 125
Decreased peripheral brain-derived neurotrophic factor levels in Alzheimer’s disease: a meta-analysis study (N=7277)
Xiao‐Yan Qin, C Cao, Niamh X. Cawley, et al.
Molecular Psychiatry (2016) Vol. 22, Iss. 2, pp. 312-320
Closed Access | Times Cited: 120
Molecular mechanisms of brain-derived neurotrophic factor in neuro-protection: Recent developments
Hailin Zhao, Azeem Alam, Chun-Yin San, et al.
Brain Research (2017) Vol. 1665, pp. 1-21
Closed Access | Times Cited: 111
Biomarkers for Alzheimer’s Disease Early Diagnosis
Eva Ausó, Violeta Gómez‐Vicente, Gema Esquiva
Journal of Personalized Medicine (2020) Vol. 10, Iss. 3, pp. 114-114
Open Access | Times Cited: 108
Assessment of late-life depression via self-report measures: a review
Michela Balsamo, Fedele Cataldi, Leonardo Carlucci, et al.
Clinical Interventions in Aging (2018) Vol. Volume 13, pp. 2021-2044
Open Access | Times Cited: 104
Neuroprotective effect of rutin against colistin-induced oxidative stress, inflammation and apoptosis in rat brain associated with the CREB/BDNF expressions
Hamit Çelik, Fatih Mehmet Kandemir, Cüneyt Çağlayan, et al.
Molecular Biology Reports (2020) Vol. 47, Iss. 3, pp. 2023-2034
Closed Access | Times Cited: 101
Natural Compounds as Medical Strategies in the Prevention and Treatment of Psychiatric Disorders Seen in Neurological Diseases
Esra Küpeli Akkol, İrem Tatlı Çankaya, Gökçe Şeker Karatoprak, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 87
Crocetin ameliorates chronic restraint stress-induced depression-like behaviors in mice by regulating MEK/ERK pathways and gut microbiota
Susu Lin, Qiaoqiao Li, Shanshan Jiang, et al.
Journal of Ethnopharmacology (2020) Vol. 268, pp. 113608-113608
Closed Access | Times Cited: 80
Investigation of the Molecular Role of Brain-Derived Neurotrophic Factor in Alzheimer’s Disease
Pragya Girotra, Tapan Behl, Aayush Sehgal, et al.
Journal of Molecular Neuroscience (2021) Vol. 72, Iss. 2, pp. 173-186
Closed Access | Times Cited: 60
Linking the Amyloid, Tau, and Mitochondrial Hypotheses of Alzheimer’s Disease and Identifying Promising Drug Targets
Zdeněk Fišar
Biomolecules (2022) Vol. 12, Iss. 11, pp. 1676-1676
Open Access | Times Cited: 53
Human tau accumulation promotes glycogen synthase kinase-3β acetylation and thus upregulates the kinase: A vicious cycle in Alzheimer neurodegeneration
Qiuzhi Zhou, Shihong Li, Mengzhu Li, et al.
EBioMedicine (2022) Vol. 78, pp. 103970-103970
Open Access | Times Cited: 50
GSK3: A potential target and pending issues for treatment of Alzheimer's disease
Jiahui Zhao, Mengying Wei, Min‐Song Guo, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 7
Open Access | Times Cited: 13
Nicotinamide riboside alleviates alcohol-induced depression-like behaviours in C57BL/6J mice by altering the intestinal microbiota associated with microglial activation and BDNF expression
Yushan Jiang, Ying Liu, Ming‐Qing Gao, et al.
Food & Function (2019) Vol. 11, Iss. 1, pp. 378-391
Closed Access | Times Cited: 73
Interventional programmes to improve cognition during healthy and pathological ageing: Cortical modulations and evidence for brain plasticity
Jesús Cespón, Carlo Miniussi, Maria Concetta Pellicciari
Ageing Research Reviews (2018) Vol. 43, pp. 81-98
Open Access | Times Cited: 72
Page 1 - Next Page

Scroll to top